Gene Sequencing Co. ArcherDX Scores $60M Funding Round
Molecular technology firm ArcherDX on Wednesday said investors handed over $60 million in a recent funding round as the company looks to ramp up operations and improve existing diagnostic and disease...To view the full article, register now.
Already a subscriber? Click here to view full article